- Datum13.05.2025
- Uhrzeit08:00 - 09:00 Uhr
- Veranstalter
XTB
Armata Pharmaceuticals Inc. Chart

Charts analysieren
wie die Profis?
Nutze das Charting-Widget auf dem stock3 Terminal für Deine eigene Analyse und handle direkt aus dem Chart bei Deinem Broker.
Chart analysieren
Armata Pharmaceuticals Inc. Realtime-Kurs
Handelsplatz | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
---|---|---|---|---|---|---|
L&S | VK | |||||
Stuttgart | VK | |||||
Baader | VK |
Passende Produkte
WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
---|
Wertentwicklung (Nasdaq Basic)
Passender Service zu Armata Pharmaceuticals Inc.
Webinar zu Armata Pharmaceuticals Inc.
Kursinformationen (Nasdaq Basic)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)0,898-3,415
- Jahrestief / Hoch ($)0,898-2,370
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von Armata Pharmaceuticals Inc.
Termine von Armata Pharmaceuticals Inc.
Beschreibung
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has a partnership agreement with Merck & Co. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California.